Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor

Abstract Background Erythropoietin (EPO) is a hypoxia-inducible stimulator of erythropoiesis. Besides its traditional application in anemia therapy, it offers an effective treatment in the cancer patients, especially those who receive chemotherapy. Several reports indicated that it could promote the...

Full description

Bibliographic Details
Published in:	Cancer Cell International
Main Authors:	Shuo Miao, Su-Mei Wang, Xue Cheng, Yao-Feng Li, Qing-Song Zhang, Gang Li, Song-Qing He, Xiao-Ping Chen, Ping Wu
Format:	Article
Language:	English
Published:	BMC 2017-12-01
Subjects:	Erythropoietin Erythropoietin receptor Hepatocellular carcinoma Hypoxia Proliferation
Online Access:	http://link.springer.com/article/10.1186/s12935-017-0494-7

Similar Items

Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01)

Expression of erythropoietin receptor protein in the mouse hippocampus in response to normobaric hypoxia
by: F. Fussing, et al.
Published: (2024-02-01)

Gamma-Aminobutyric Acid Increases Erythropoietin by Activation of Citrate Cycle and Stimulation of Hypoxia-Inducible Factors Expression in Rats
by: Keun-Tae Park, et al.
Published: (2020-04-01)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
by: Carolina Castillo Hernández, et al.
Published: (2017-01-01)

The Acute Effect of Erythropoietin on Mean Platelet Volume Levels during Hypoxia Reoxygenation Injury in Rats
by: Constantinos Tsompos, et al.
Published: (2016-12-01)

The effect of erythropoietin on calcium levels during hypoxia reoxygenation injury in rats
by: Constantinos Tsompos, et al.
Published: (2016-04-01)

Effects of Endogen Erythropoietin on Parathormone Secretion
by: Edip Gönüllü, et al.
Published: (2021-12-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

Erythropoietin Nanopariticles: Therapy for Cerebral Ischemic Injury and Metabolize in Kidney
by: Ting Wang, et al.
Published: (2010-03-01)

Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-02-01)

Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer′s disease
by: Zohreh Arabpoor, et al.
Published: (2012-01-01)

Deficiency of lysophosphatidic acid receptor 3 decreases erythropoietin production in hypoxic mouse kidneys
by: Nan Yin, et al.
Published: (2024-11-01)

Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation
by: Yukiko Yasuoka, et al.
Published: (2020-06-01)

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study
by: Yasuhiro Mochida, et al.
Published: (2022-08-01)

Erythropoietin receptor gene polymorphism in Indian pig lines
by: S PRAMOD, et al.
Published: (2016-05-01)

Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis
by: Xinyi Lyu, et al.
Published: (2025-03-01)

Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke
by: Damjan Osredkar, et al.
Published: (2010-05-01)

Recombinant Human Erythropoietin Augments Neovascularization Responses in a Neonatal Rat Model of Premature Brain Damage by Phosphatidylinositol 3 Kinase/Akt Pathway
by: Da-Fan Yu, et al.
Published: (2017-01-01)

The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
by: Martha Catalina Rivera-Cervantes, et al.
Published: (2019-02-01)

Effect of erythropoietin hormone supplementation on renal functions and the level of hypoxia-inducible factor-1α in rat kidneys with experimentally induced diabetic nephropathy
by: Alaa El Din Hassan, et al.
Published: (2014-03-01)

The Neural Crest as the First Production Site of the Erythroid Growth Factor Erythropoietin
by: Ikuo Hirano, et al.
Published: (2019-06-01)

Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients
by: Yuki Kawai, et al.
Published: (2021-09-01)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
by: Hamid Nasri
Published: (2013-01-01)

Polycythemia caused by erythropoietin‐producing hemangiosarcoma
by: Osamu Imataki, et al.
Published: (2024-02-01)

Effects of Roxadustat on Erythropoietin Production in the Rat Body
by: Yukiko Yasuoka, et al.
Published: (2022-02-01)

Study the relationship of erythropoietin and chronic obstructive pulmonary disease
by: R.I. El-Korashy, et al.
Published: (2012-07-01)

PURE RED CELL APLASIA INDUCED BY ERYTHROPOIETIN
by: MIhajlovic Filip, et al.
Published: (2018-05-01)

Low sirtuin-1 levels are linked to erythropoietin resistance in hemodialysis patients
by: Ebru Hekimgil, et al.
Published: (2025-12-01)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
by: Farooqahmed S. Kittur, et al.
Published: (2023-04-01)

Histopathological Evaluation of Erythropoietin's Protective Effect Against Doxorubicin-Induced Hepatotoxicity
by: Zeena Jasim Saddam, et al.
Published: (2025-05-01)

Role of erythropoietin in methotrexate-induced nephrotoxicity in adult male albino rats
by: Ahmed Hassan Al-Rashidy, et al.
Published: (2018-05-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

Diagnostic Value of Erythropoietin Levels in Umbilical Cord Blood in Hypoxic-Ischemic Brain Injury: Clinical Observational Cross-Sectional Study
by: S. B. Berezhanskaya, et al.
Published: (2022-12-01)

Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
by: Hong-Mou Shih, et al.
Published: (2021-11-01)

Hydronephrosis-Induced Polycythemia with Low Erythropoietin Level: A Case Report and Literature Review
by: Chia-Cheng Chang, et al.
Published: (2024-12-01)

Elevated Erythropoietin and Multicystic Neoplasm of the Pancreas
by: Qiang Nai, et al.
Published: (2015-03-01)

The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients
by: N. Stepanova, et al.
Published: (2018-09-01)

Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction
by: Nahm CH, et al.
Published: (2023-08-01)

Resistance to recombinant human erythropoietin therapy in haemodialysis patients
by: Elísio Costa, et al.
Published: (2009-06-01)

Baseline Soluble Anti-erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study
by: Ying Zhang, et al.
Published: (2020-04-01)